ArticleBMC pediatrics2025
Bisphenol exposure in preterm neonates: a cohort study with measurements at admission and discharge in a neonatal intensive care unit in Ankara, Türkiye.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
This study assessed bisphenol exposure in preterm infants (born before 35 weeks of gestation) hospitalized in a neonatal intensive care unit (NICU), along with associated prenatal exposure. Fifty-eight infants and 48 mothers were included. Bisphenol A (BPA) and bisphenol F (BPF) levels were measured in maternal urine, cord blood, and infant urine samples using high-performance liquid chromatography (HPLC). There was a significant negative association between maternal urine BPF (MuBPF) and the newborn's birth weight percentile. A significant positive correlation was found between the BPA levels of the infant's urine taken on the first day (NuBPA1) and the second sample taken on the last day (NuBPA2) in the NICU. There was a significant negative association between tertile levels of cord BPA (cBPA) and stretched penile length (SPL). NuBPF1 levels in the first-born babies were significantly higher compared to the later-borns. Detectable NuBPF1 levels and decreased NuBPF2 compared to NuBPF1 levels were observed more frequently in males. Cord BPA (cBPA) and BPF (cBPF) levels did not significantly correlate with maternal or infant urinary levels. No association was found between NICU procedures and BPA or BPF exposure levels. The absence of significant associations between neonatal urine BPA levels and both maternal urine and cord blood BPA, as well as NICU procedures, suggests that newborns may be exposed to these chemicals through other, unpredictable sources that were not captured in this study. The study highlights the need to minimize BPA and BPF exposure, especially during pregnancy and NICU stays, to protect fetal health and prevent future issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.